Picture of Cencora logo

COR Cencora Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
2024
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue189,894213,989238,587262,173293,959
Cost of Revenue
Gross Profit5,1836,7748,3358,8079,793
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses195,051211,635236,176259,792291,783
Operating Profit-5,1582,3542,4112,3812,175
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-5,2942,2222,1832,1612,004
Provision for Income Taxes
Net Income After Taxes-3,4001,5451,6671,7331,519
Minority Interest
Net Income Before Extraordinary Items
Net Income-3,4091,5401,6991,7451,509
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-3,4091,5401,6991,7451,509
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS6.158.469.429.1310.8
Dividends per Share